Min Mu

1.7k total citations
48 papers, 1.3k citations indexed

About

Min Mu is a scholar working on Biomedical Engineering, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Min Mu has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Biomedical Engineering, 15 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in Min Mu's work include Nanoplatforms for cancer theranostics (21 papers), Advanced Nanomaterials in Catalysis (8 papers) and Nanoparticle-Based Drug Delivery (7 papers). Min Mu is often cited by papers focused on Nanoplatforms for cancer theranostics (21 papers), Advanced Nanomaterials in Catalysis (8 papers) and Nanoparticle-Based Drug Delivery (7 papers). Min Mu collaborates with scholars based in China and Saudi Arabia. Min Mu's co-authors include Gang Guo, Rangrang Fan, Aiping Tong, Di Chuan, Bo Han, Jianguo Xu, Bingwen Zou, Na Zhao, Huan Hou and Caili Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.

In The Last Decade

Min Mu

43 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Min Mu China 20 594 346 344 213 207 48 1.3k
Hanqing Qian China 25 725 1.2× 752 2.2× 689 2.0× 254 1.2× 249 1.2× 58 1.8k
Behrooz Johari Iran 23 413 0.7× 317 0.9× 498 1.4× 284 1.3× 105 0.5× 72 1.3k
Wenquan Ou South Korea 22 793 1.3× 523 1.5× 544 1.6× 243 1.1× 241 1.2× 34 1.5k
Xu Song China 20 505 0.9× 487 1.4× 630 1.8× 163 0.8× 157 0.8× 57 1.4k
Aeju Lee South Korea 23 569 1.0× 401 1.2× 681 2.0× 160 0.8× 195 0.9× 38 1.4k
Laure Gibot France 19 676 1.1× 376 1.1× 383 1.1× 153 0.7× 148 0.7× 53 1.4k
Jiaqi Yan China 20 613 1.0× 319 0.9× 488 1.4× 73 0.3× 162 0.8× 45 1.3k
Giovanna Lollo France 24 318 0.5× 500 1.4× 515 1.5× 143 0.7× 64 0.3× 51 1.4k
Wenjun Le China 17 839 1.4× 440 1.3× 482 1.4× 106 0.5× 461 2.2× 40 1.5k
Diana Rafael Spain 21 385 0.6× 410 1.2× 490 1.4× 195 0.9× 83 0.4× 42 1.2k

Countries citing papers authored by Min Mu

Since Specialization
Citations

This map shows the geographic impact of Min Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Mu more than expected).

Fields of papers citing papers by Min Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Mu. The network helps show where Min Mu may publish in the future.

Co-authorship network of co-authors of Min Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Min Mu. A scholar is included among the top collaborators of Min Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Mu. Min Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mu, Min, Bo Chen, Nianyong Chen, et al.. (2025). A fusion of oncolytic viruses and bispecific T-cell engagers for triple negative breast cancer immunotherapy. Chemical Engineering Journal. 508. 160853–160853. 1 indexed citations
2.
Zhou, Lingfeng, Bo Chen, Hui Li, et al.. (2025). Targeted reduction-responsive nanovehicles for photodynamic therapy-primed immunotherapy in melanoma. Journal of Pharmaceutical Analysis. 15(12). 101311–101311.
3.
Wang, Yinggang, Min Mu, Rangrang Fan, et al.. (2025). Single-atom enzymes: from nano-enzyme evolution to the biomedical frontier of precision catalysis. Coordination Chemistry Reviews. 549. 217317–217317. 1 indexed citations
4.
Cao, Weiya, Bing Li, Haibo Jin, et al.. (2025). S100a8 inhibitor Paquinimod attenuates coal dust-induced pulmonary fibrosis via blocking neutrophils-S100a8-Tlr4-macrophages signaling axis. International Immunopharmacology. 161. 115020–115020.
5.
Mu, Min, Guoqing Wang, Hui Li, et al.. (2025). Decomposable STING nanoagonist-amplified oncolytic virotherapy through remodeling the immunosuppressive microenvironment of triple-negative breast cancer. Journal of Materials Chemistry B. 13(11). 3685–3699. 2 indexed citations
7.
Mu, Min, Wei Yu, Rangrang Fan, et al.. (2025). Engineering polyphenol-based osteogenic system for bone and cartilage repair: Transplantation, tissue engineering, and organoid. Journal of Advanced Research. 82. 1027–1048. 1 indexed citations
8.
Chen, Bo, Yinggang Wang, Min Mu, et al.. (2025). Boosting Peroxidase-Mimetic Activity of FeMn-NCe Dual-Atom Radiosensitizing Nanozymes for Augmented Radiodynamic Immunotherapy. ACS Nano. 19(10). 10147–10161. 14 indexed citations
10.
Mu, Min, et al.. (2024). The application of bacteria-nanomaterial hybrids in antitumor therapy. Journal of Nanobiotechnology. 22(1). 536–536. 13 indexed citations
11.
Liang, Xiaoyan, et al.. (2024). Metal‐organic frameworks‐based nanomedicines to promote cancer immunotherapy: Recent advances and future directions. SHILAP Revista de lepidopterología. 3(4). 5 indexed citations
12.
Mu, Min, Hui Li, Rangrang Fan, et al.. (2024). Augmented the sensitivity of photothermal-ferroptosis therapy in triple-negative breast cancer through mitochondria-targeted nanoreactor. Journal of Controlled Release. 375. 733–744. 23 indexed citations
13.
Wang, Xiaoxiao, et al.. (2024). Recent Development and Advances on Polysaccharide Composite Scaffolds for Dental and Dentoalveolar Tissue Regeneration. Polymer Reviews. 65(1). 47–103. 4 indexed citations
14.
Mu, Min, Zongliang Zhang, Yang Nian, et al.. (2024). Systemic delivery of tannic acid-ferric-masked oncolytic adenovirus reprograms tumor microenvironment for improved therapeutic efficacy in glioblastoma. Cancer Gene Therapy. 31(12). 1804–1817. 6 indexed citations
15.
Li, Hui, et al.. (2023). MXene-based nanomaterials for antibacterial and wound healing. Materials Research Letters. 12(2). 67–87. 25 indexed citations
16.
Zhao, Shasha, Yuelong Wang, Min Mu, et al.. (2022). Genome-scale CRISPR–Cas9 screen reveals novel regulators of B7-H3 in tumor cells. Journal for ImmunoTherapy of Cancer. 10(6). e004875–e004875. 13 indexed citations
17.
Liang, Xiaoyan, Min Mu, Rangrang Fan, Bingwen Zou, & Gang Guo. (2022). Functionalized chitosan as a promising platform for cancer immunotherapy: A review. Carbohydrate Polymers. 290. 119452–119452. 57 indexed citations
18.
Mu, Min, Xiaoyan Liang, Na Zhao, et al.. (2022). Boosting ferroptosis and microtubule inhibition for antitumor therapy via a carrier-free supermolecule nanoreactor. Journal of Pharmaceutical Analysis. 13(1). 99–109. 31 indexed citations
19.
Mu, Min, Haifeng Chen, Rangrang Fan, et al.. (2021). A Tumor-Specific Ferric-Coordinated Epigallocatechin-3-gallate cascade nanoreactor for glioblastoma therapy. Journal of Advanced Research. 34. 29–41. 35 indexed citations
20.
Lu, Xuke, Xiugui Chen, Min Mu, et al.. (2016). Genome-Wide Analysis of Long Noncoding RNAs and Their Responses to Drought Stress in Cotton (Gossypium hirsutum L.). PLoS ONE. 11(6). e0156723–e0156723. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026